Your browser doesn't support javascript.
loading
IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid.
James, Talia; Salman, Sam; Stevenson, Brittany; Bundell, Christine; Kelly, Gavin; Nolan, David; John, Mina.
Afiliación
  • James T; Department of Clinical Immunology, Royal Perth Hospital, Perth, WA 6000, Australia. Electronic address: Talia.James@health.wa.gov.au.
  • Salman S; Department of Clinical Immunology, Royal Perth Hospital, Perth, WA 6000, Australia; Department of Immunology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, WA 6009, Australia; Medical School, University of Western Australia, Perth, WA 6009, Australia.
  • Stevenson B; Department of Clinical Immunology, Royal Perth Hospital, Perth, WA 6000, Australia; Department of Immunology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, WA 6009, Australia.
  • Bundell C; Department of Immunology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, WA 6009, Australia.
  • Kelly G; Department of Clinical Immunology, Royal Perth Hospital, Perth, WA 6000, Australia.
  • Nolan D; Department of Clinical Immunology, Royal Perth Hospital, Perth, WA 6000, Australia.
  • John M; Department of Clinical Immunology, Royal Perth Hospital, Perth, WA 6000, Australia; Institute of Immunology and Infectious Diseases (IIID), Murdoch University, Murdoch, WA 6150, Australia. Electronic address: Mina.John@health.wa.gov.au.
Clin Immunol ; 198: 54-56, 2019 01.
Article en En | MEDLINE | ID: mdl-30557620

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina E / Penfigoide Ampolloso / Omalizumab Límite: Aged / Humans / Male Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina E / Penfigoide Ampolloso / Omalizumab Límite: Aged / Humans / Male Idioma: En Revista: Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos